Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05XPL
|
|||
| Former ID |
DNC013763
|
|||
| Drug Name |
2-Methyl-beta-carboline-2-ium iodide
|
|||
| Synonyms |
2-methylnorharmane iodide; CHEMBL455600; MolPort-001-815-824; AKOS024332881
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H11N2+
|
|||
| Canonical SMILES |
C[N+]1=CC2=C(C=C1)C3=CC=CC=C3N2
|
|||
| InChI |
1S/C12H10N2/c1-14-7-6-10-9-4-2-3-5-11(9)13-12(10)8-14/h2-8H,1H3/p+1
|
|||
| InChIKey |
UDHBHTHWWOQPBW-UHFFFAOYSA-O
|
|||
| CAS Number |
CAS 17994-14-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem. 2010 May 13;53(9):3611-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.